AusCann announces immediate access for Chilean patients

Company News

by Anna Napoli

Medical cannabis company, AusCann (ASX:AC8) has announced its Chilean partner Fundacion Daya has established a scheme which enables immediate access for Chilean patients to medicinal cannabis.

The special access scheme allows doctors to prescribe medicinal cannabis to patients prior to completion of current trials for product registration.

A similar access scheme is used in Australia, prescriptions are approved on a case by case basis.

The process enables access to the products while clinical trials are being completed.

The company says the access scheme will accelerate the goal of supplying final dose form medicines for pain treatment in Latin America.

Shares in AusCann (ASX:AC8) are trading flat at $1.62.



Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.